These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11738474)
1. Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases. Gentile V; Violante V; D'Amico B; Illiano M; Luongo A Neurochem Int; 2002 Jan; 40(1):79-83. PubMed ID: 11738474 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiological roles of transglutaminase - catalyzed reactions in the pathogenesis of human diseases. Martin A; De Vivo G; Iannaccone M; Stefanile A; Serretiello E; Gentile V Inflamm Allergy Drug Targets; 2012 Aug; 11(4):278-84. PubMed ID: 22680626 [TBL] [Abstract][Full Text] [Related]
3. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease. Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095 [TBL] [Abstract][Full Text] [Related]
4. The progression of coeliac disease: its neurological and psychiatric implications. Campagna G; Pesce M; Tatangelo R; Rizzuto A; La Fratta I; Grilli A Nutr Res Rev; 2017 Jun; 30(1):25-35. PubMed ID: 27976606 [TBL] [Abstract][Full Text] [Related]
5. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003 [TBL] [Abstract][Full Text] [Related]
6. Transglutaminase and the pathogenesis of coeliac disease. Stenberg P; Roth EB; Sjöberg K Eur J Intern Med; 2008 Mar; 19(2):83-91. PubMed ID: 18249302 [TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease. Stenberg P; Roth B; Wollheim FA Eur J Intern Med; 2009 Dec; 20(8):749-55. PubMed ID: 19892302 [TBL] [Abstract][Full Text] [Related]
8. Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases. De Vivo G; Di Lorenzo R; Ricotta M; Gentile V Curr Med Chem; 2009; 16(36):4767-73. PubMed ID: 19929789 [TBL] [Abstract][Full Text] [Related]
9. Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders. De Vivo G; Martin A; Trotta T; Gentile V Inflamm Allergy Drug Targets; 2008 Mar; 7(1):24-9. PubMed ID: 18473897 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease. Amantea G; Cammarano M; Zefferino L; Martin A; Romito G; Piccirillo M; Gentile V Front Biosci; 2006 Jan; 11():249-55. PubMed ID: 16146729 [TBL] [Abstract][Full Text] [Related]
11. Do gliadin and tissue transglutaminase mediate PPAR downregulation in intestinal cells of patients with coeliac disease? De Re V; Simula MP; Notarpietro A; Canzonieri V; Cannizzaro R; Toffoli G Gut; 2010 Dec; 59(12):1730-1. PubMed ID: 20805313 [No Abstract] [Full Text] [Related]
12. Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic. Martin A; Romito G; Pepe I; De Vivo G; Merola MR; Limatola A; Gentile V Curr Med Chem; 2006; 13(16):1895-902. PubMed ID: 16842200 [TBL] [Abstract][Full Text] [Related]
13. The spectrum of coeliac disease in children. Catassi C; Fabiani E Baillieres Clin Gastroenterol; 1997 Sep; 11(3):485-507. PubMed ID: 9448912 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of coeliac disease. Dewar D; Pereira SP; Ciclitira PJ Int J Biochem Cell Biol; 2004 Jan; 36(1):17-24. PubMed ID: 14592529 [TBL] [Abstract][Full Text] [Related]
15. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411 [TBL] [Abstract][Full Text] [Related]
16. The industrial food additive, microbial transglutaminase, mimics tissue transglutaminase and is immunogenic in celiac disease patients. Matthias T; Jeremias P; Neidhöfer S; Lerner A Autoimmun Rev; 2016 Dec; 15(12):1111-1119. PubMed ID: 27640315 [TBL] [Abstract][Full Text] [Related]
18. Anti-transglutaminase antibodies and coeliac disease. Miller A; Paspaliaris W; Elliott PR; d'Apice A Aust N Z J Med; 1999 Apr; 29(2):239-42. PubMed ID: 10342024 [TBL] [Abstract][Full Text] [Related]
19. Human jejunal transglutaminase: demonstration of activity, enzyme kinetics and substrate specificity with special relation to gliadin and coeliac disease. Bruce SE; Bjarnason I; Peters TJ Clin Sci (Lond); 1985 May; 68(5):573-9. PubMed ID: 2858282 [TBL] [Abstract][Full Text] [Related]
20. A comparison of antibodies to tissue transglutaminase with conventional serological tests in the diagnosis of coeliac disease. Johnston SD; McMillan SA; Collins JS; Tham TC; McDougall NI; Murphy P Eur J Gastroenterol Hepatol; 2003 Sep; 15(9):1001-4. PubMed ID: 12923373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]